Alimera Sciences

1 follower

‌

Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

President, CEO & Interim CFO

Rick Eiswirth

Collapse

CMO & SVP, Corporate Communications & Managed Markets

COO & SVP, Commercial Operations Europe

Russell Skibsted

CFO & SVP

Chief Retina Specialist

Vice President, Thought Leader Engagement At Alimera Sciences

Christopher Visick

Vice President, General Counsel

Laura Cegala Sphr, Gphr

Vice President, Human Capital

Senior Director, Global Quality Assurance

Chairman Of The Board

Regional Sales Director

Brittany Underhill

Associate Director, Financial Reporting

Vice President, Managed Markets

Vice President Of Global Marketing/head Of Commercial Excellence

Medical Director, UK & Eire

Vp, Sales Director Europe

Vice President , Medical Director Uk, Head Of Medical Affairs Europe

Senior Director, Finance & Corporate Controller

Executive Director Marketing

Teams

View all

Leadership Team

4 members

CEO and Executive Team

3 members

Discover similar companies

TRICIDA

1 follower

Emmaus Medical

4 followers

Catalyst Pharmaceuticals

2 followers

Spectrum Pharmaceuticals

1 follower

DURECT

1 follower